JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB193332

PE Anti-CD28 antibody [CB28]

Be the first to review this product! Submit a review

|

(1 Publication)

Mouse Monoclonal CD28 antibody - conjugated to PE. Suitable for Flow Cyt, SDS-PAGE and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human CD28.

View Alternative Names

CD28, T-cell-specific surface glycoprotein CD28, TP44

3 Images
Flow Cytometry - PE Anti-CD28 antibody [CB28] (AB193332)
  • Flow Cyt

Supplier Data

Flow Cytometry - PE Anti-CD28 antibody [CB28] (AB193332)

Flow cytometry overlay histogram of PFA-fixed Jurkat cells labeling [CD28] with ab193332 at 1-2ug/million cells (Blue) compared with isotype control (Red). Secondary antibody was goat anti-mouse IgG-CF488.

SDS-PAGE - PE Anti-CD28 antibody [CB28] (AB193332)
  • SDS-PAGE

Supplier Data

SDS-PAGE - PE Anti-CD28 antibody [CB28] (AB193332)

SDS-PAGE Analysis of Purified CD28 Mouse Monoclonal Antibody (CB28). Confirmation of Integrity and Purity of Antibody.

SDS-PAGE - PE Anti-CD28 antibody [CB28] (AB193332)
  • SDS-PAGE

Supplier Data

SDS-PAGE - PE Anti-CD28 antibody [CB28] (AB193332)

SDS-PAGE Analysis of Purified CD28 Mouse Monoclonal Antibody (CB28) (unconjugated). Confirmation of Purity and Integrity of Antibody.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

CB28

Isotype

IgG1

Light chain type

kappa

Conjugation

PE

Excitation/Emission

Ex: 480;565nm, Em: 578nm

Carrier free

No

Reacts with

Human

Applications

SDS-PAGE, Flow Cyt

applications

Immunogen

Recombinant Fragment Protein within Human CD28.

P10747

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "SDSPAGE" : {"fullname" : "SDS-PAGE", "shortname":"SDS-PAGE"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "SDSPAGE-species-checked": "testedAndGuaranteed", "SDSPAGE-species-dilution-info": "", "SDSPAGE-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: PBS, 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store in the dark

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD28 also known as T-cell-specific surface glycoprotein CD28 or TP44 plays an important role as a co-stimulatory receptor on T cells. This glycoprotein has a molecular mass of about 44 kDa and is located mainly on the cell surface of T cells. CD28 expression also occurs on thymocytes and some B cells. It forms part of the immunoglobulin superfamily featuring in significant antibody interactions. Researchers often use anti-CD28 antibodies for various immunological assays including CD28 ELISA to study its function.
Biological function summary

CD28 co-stimulates T cells after antigen presentation. It enhances T cell proliferation survival and cytokine production. CD28 functions alongside the T cell receptor (TCR) complex mediating signals that promote full T cell activation. This interaction amplifies the immune response forming an important axis of immune system communication. CD28 interacts with its ligands B7-1 (CD80) and B7-2 (CD86) found on antigen-presenting cells (APCs) illustrating its role in immune system dynamics.

Pathways

CD28 is integral to the PI3K/Akt and MAPK/ERK signaling pathways. These pathways conduct signals critical for cellular growth and survival linking CD28 to downstream transcription factors. The interaction with another protein CTLA-4 acts as a regulatory balance for CD28 signaling preventing over-activation of T cells. This balance influences immune homeostasis and tolerance providing a framework for understanding costimulatory and inhibitory signaling.

CD28's role becomes evident in autoimmune diseases and transplant rejection. Abnormal CD28 signaling links to rheumatoid arthritis where inappropriate T cell activation occurs. Similarly CD28 activity contributes to organ transplant rejection by stimulating T cell-mediated responses against transplanted tissues. CTLA-4 through regulatory feedback can modify these effects providing therapeutic target strategies for managing such disorders. Efforts to modulate CD28 activity involve developing therapeutic agents such as anti-CD28 monoclonal antibodies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor that plays a role in T-cell activation, proliferation, survival and the maintenance of immune homeostasis (PubMed : 1650475, PubMed : 7568038). Functions not only as an amplifier of TCR signals but delivers unique signals that control intracellular biochemical events that alter the gene expression program of T-cells (PubMed : 24665965). Stimulation upon engagement of its cognate ligands CD80 or CD86 increases proliferation and expression of various cytokines in particular IL2 production in both CD4(+) and CD8(+) T-cell subsets (PubMed : 1650475, PubMed : 35397202). Mechanistically, ligation induces recruitment of protein kinase C-theta/PRKCQ and GRB2 leading to NF-kappa-B activation via both PI3K/Akt-dependent and -independent pathways (PubMed : 21964608, PubMed : 24665965, PubMed : 7568038). In conjunction with TCR/CD3 ligation and CD40L costimulation, enhances the production of IL4 and IL10 in T-cells (PubMed : 8617933).. Isoform 3. Enhances CD40L-mediated activation of NF-kappa-B and kinases MAPK8 and PAK2 in T-cells (PubMed : 15067037).
See full target information CD28

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in pharmacology 8:960 PubMed29354058

2018

SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Shuang Dai,Yuanliang Yan,Zhijie Xu,Shuangshuang Zeng,Long Qian,Lei Huo,Xuejun Li,Lunquan Sun,Zhicheng Gong
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com